(Q41899321)

13 October 2017

Antibiotic-free production of a herpes simplex virus 2 DNA vaccine in a high yield cGMP process (English)

1 reference

13 October 2017

Jared Nelson

1

1 reference

13 October 2017

Stephen Rodriguez

2

1 reference

13 October 2017

Neil Finlayson

3

1 reference

13 October 2017

Jim Williams

4

1 reference

13 October 2017

Aaron Carnes

5

1 reference

13 October 2017

30 July 2013

1 reference

Human Vaccines & Immunotherapeutics

13 October 2017

1 reference

13 October 2017

9

1 reference

13 October 2017

10

1 reference

13 October 2017

2211-2215

1 reference

Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2.

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906406

Improved antibiotic-free plasmid vector design by incorporation of transient expression enhancers

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906406

Plasmid DNA fermentation strain and process-specific effects on vector yield, quality, and transgene expression

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906406

Critical design criteria for minimal antibiotic-free plasmid vectors necessary to combine robust RNA Pol II and Pol III-mediated eukaryotic expression with high bacterial production yields

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906406

Maternal and neonatal herpes simplex virus infections

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906406

Generic plasmid DNA production platform incorporating low metabolic burden seed-stock and fed-batch fermentation processes.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906406

Plasmid DNA manufacturing technology

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906406

Bioprocess engineering issues that would be faced in producing a DNA vaccine at up to 100 m3 fermentation scale for an influenza pandemic.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906406

High cell-density culture of Escherichia coli

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906406

Inducible Escherichia coli fermentation for increased plasmid DNA production.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906406

Successful parallel development and integration of a plasmid-based biologic, container/closure system and electrokinetic delivery device.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3906406

Production of pharmaceutical-grade plasmids at high concentration and high supercoiled percentage

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23899469

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4161/HV.25048

1 reference

13 October 2017

1 reference

13 October 2017

PubMed publication ID

23899469

1 reference